@arkangel256 I dont know, but what are the odds that in the IND we submitted there was a recommendation/suggestion that the FDA allow the primary endpoint to be reduction in ICP. Is that even something that can be submitted in an IND?
Ann: Trading Halt, page-36
Add IXC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
7.8¢ |
Change
0.018(30.0%) |
Mkt cap ! $5.862M | |||
| Open | High | Low | Value | Volume |
| 7.4¢ | 7.8¢ | 7.3¢ | $13.65K | 182.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 50000 | 7.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 7.6¢ | 10000 | 1 |
View Market Depth
| Last trade - 10.23am 07/06/2024 (20 minute delay) ? |
|
|||||
|
Last
6.9¢ |
Change
0.018 ( 2.99 %) |
||||
| Open | High | Low | Volume | ||
| 7.2¢ | 7.4¢ | 6.9¢ | 82176 | ||
| Last updated 12.56pm 07/06/2024 ? | |||||
| IXC (ASX) Chart |